Ironwood Pharmaceuticals Inc (FRA:I76)
€ 4.54 -0.1 (-2.16%) Market Cap: 735.32 Mil Enterprise Value: 1.22 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 55/100

Ironwood Pharmaceuticals Inc at Morgan Stanley Healthcare Conference Transcript

Sep 11, 2019 / 04:15PM GMT
Release Date Price: €8.38 (+6.08%)
David Neil Lebowitz
Morgan Stanley, Research Division - VP

Good afternoon, or -- yes, good afternoon. Thank you very much for coming to the Morgan Stanley Healthcare Conference, and before I get going, let me read the requisite disclosures. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at www.morganstanley.com/researchdisclosures or at the registration desk. I'm one of the biotechnology analysts here, my name is Dave Lebowitz. And on stage with me, I'm happy to have Ironwood Pharmaceuticals. If you could introduce yourselves, and I guess start by telling us about the company, and where you come from and certainly, there's been a lot of change in the last year.

Mark Mallon;Thomas A. McCourt
Ironwood Pharmaceuticals, Inc. - CEO & Director;Ironwood Pharmaceuticals, Inc. -

Yes. Sure. Tom, why don't you introduce yourself.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot